A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Emmaus Medical, Inc.

ClinicalTrials.gov Identifier:

NCT01179217

First received: May 21, 2010

Last updated: November 30, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)